Skip to main content
iwCLL 2025 Main banner
Final Program


iwCLL X / Twitter

Oral

1023 - Clinical and biological impact of MYC Overexpression in Chronic Lymphocytic Leukemia with and without TP53 Disruption

    Primary Author / Presenter(s)

  • AG

    Alba Garrote de Barros, MSc

    Predoctoral
    Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, CIBERONC, ES 28041
    Madrid, Madrid, Spain

    • Co-Author(s)

  • JP

    Juan Pérez Fernández, BSc

    Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid
    Madrid, Madrid, Spain

  • AA

    Andrés Arroyo Barea, MSc

    Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, CIBERONC, ES 28041
    Madrid, Madrid, Spain

  • IB

    Irene Bragado García, MSc

    Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid
    Madrid, Madrid, Spain

  • RG

    Roberto García Vicente, MSc

    Predoctoral
    Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, CIBERONC, ES 28041
    Madrid, Madrid, Spain

  • RA

    Raquel Ancos Pintado, MSc

    Predoctoral
    Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid
    Madrid, Madrid, Spain

  • MV

    María Velasco Estévez, PhD

    Post-doc
    Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, CIBERONC, ES 28041
    Madrid, Madrid, Spain

  • TB

    Tycho Baumann, MD, PhD

    Clinical
    Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, CIBERONC, ES 28041
    Madrid, Madrid, Spain

  • ML

    María Linares Gómez*, PhD

    PI- Professor
    Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid
    Madrid, Madrid, Spain

  • JM

    Joaquín Martínez López*, MD, PhD

    Clinical - PI - Professor
    Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, CIBERONC, ES 28041 Madrid, Spain - Department of Medicine, Medicine School, Universidad Complutense de Madrid, ES 28040 Madrid, Spain.
    Madrid, Madrid, Spain

  • MH

    María Hernández Sánchez*, PhD

    PI- Professor
    Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid
    Madrid, Madrid, Spain